Molecules (2021)
Update date:2022-07-31
Topics:
Adornato, Ilenia
Cappiello, Mario
Del Corso, Antonella
Genovese, Massimo
Maccari, Rosanna
Moschini, Roberta
Na?, Alexandra
Nesi, Ilaria
Nguyen, Trung Ngoc
Ottanà, Rosaria
Paoli, Paolo
Wolber, Gerhard
Diabetes mellitus (DM) is a complex disease which currently affects more than 460 million people and is one of the leading cause of death worldwide. Its development implies numerous metabolic dysfunctions and the onset of hyperglycaemia-induced chronic complications. Multiple ligands can be rationally designed for the treatment of multifactorial diseases, such as DM, with the precise aim of simultaneously controlling multiple pathogenic mechanisms related to the disease and providing a more effective and safer therapeutic treatment compared to combinations of selective drugs. Starting from our previous findings that highlighted the possibility to target both aldose reductase (AR) and protein tyrosine phosphatase 1B (PTP1B), two enzymes strictly implicated in the development of DM and its complications, we synthesised 3-(5-arylidene-4-oxothiazolidin-3-yl)propanoic acids and analogous 2-butenoic acid derivatives, with the aim of balancing the effectiveness of dual AR/PTP1B inhibitors which we had identified as designed multiple ligands (DMLs). Out of the tested compounds, 4f exhibited well-balanced AR/PTP1B inhibitory effects at low micromolar concentrations, along with interesting insulin-sensitizing activity in murine C2C12 cell cultures. The SARs here highlighted along with their rationalization by in silico docking experiments into both target enzymes provide further insights into this class of inhibitors for their development as potential DML antidiabetic candidates.
View MorePurestar Chem Enterprise Co.,Ltd
website:http://www.purestarchem.com
Contact:05722157374
Address:no235.huanchengdong Rd
Jiangxi Hessence Chemicals Co., Ltd.
Contact:+86 796 3511924
Address:Chengxi Industrial Park, Jishui County, Jiangxi Province 331600 China.
Shanghai He Yang International Trading Co., Ltd.
Contact:+86-21-52043598
Address:Room 816, Blag.5, No.58 Huachi Road
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
WUHAN ENTAI TECHNOLOGY DEVELOPMENT CO.,LTD
Contact:0086-27-82330560
Address:RM1204 Fuhua Building of Wuhan Institute of Technology ,Zhuobao Road ,Wuhan ,China
Doi:10.1016/j.bmc.2008.10.065
(2009)Doi:10.1016/S0022-328X(01)01263-3
(2002)Doi:10.1039/b106992f
(2002)Doi:10.1016/j.jorganchem.2007.05.023
(2007)Doi:10.1016/S0040-4039(02)00767-0
(2002)Doi:10.1016/S0040-4039(02)00056-4
(2002)